Burn future or investigational therapies: Difference between revisions
EmanAlademi (talk | contribs) No edit summary |
EmanAlademi (talk | contribs) No edit summary |
||
| Line 3: | Line 3: | ||
A primarily [[topical]] [[therapy]] and [[topical]] therapy | |||
[[antibiotics]] | [[antibiotics]] | ||
| Line 12: | Line 12: | ||
[[respiratory]] and [[metabolic]] care and [[nutrition]]. | [[respiratory]] and [[metabolic]] care and [[nutrition]]. | ||
The use of [[systemic antibiotics]] and [[topical]] silver therapy greatly reduced [[sepsis]] related [[mortality]]. | The use of [[systemic antibiotics]] and [[topical]] silver therapy greatly reduced [[sepsis]] related [[mortality]]. | ||
Revision as of 07:24, 10 December 2020
|
Burn Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Burn future or investigational therapies On the Web |
|
American Roentgen Ray Society Images of Burn future or investigational therapies |
|
Risk calculators and risk factors for Burn future or investigational therapies |
A primarily topical therapy and topical therapy
respiratory and metabolic care and nutrition.
The use of systemic antibiotics and topical silver therapy greatly reduced sepsis related mortality.
This along with the advent of antiseptic surgical techniques, burn depth classification and skin grafting allowed the excision and coverage of full-thickness burns which resulted in greatly improved survival rates. Advancements in the methods of assessing the surface area of burns paved way for more accurate fluid resuscitation, minimizing the effects of shock and avoiding fluid over-loading.
metabolic care,
nutritional support and care of inhalation injuries further improved the outcome of burn patients.
burn care such as the use of cell and pharma-logical therapies.[1]
References
- ↑ Moiemen, NaiemS; Lee, KwangChear; Joory, Kavita (2014). "History of burns: The past, present and the future". Burns & Trauma. 2 (4): 169. doi:10.4103/2321-3868.143620. ISSN 2321-3868.